Natixis
ANGO icon

Natixis’s AngioDynamics ANGO Stock Holding History

Natixis’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.42M Buy
+92,500
New +$1.38M 0.01% 671

Other funds holding ANGO

Weber Capital Management
Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bastion Asset Management
Bastion Asset Management Montreal, Canada $229M AUM 5.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Natixis's ANGO Position: Q3 2026 in Review

Natixis opened a new position in AngioDynamics (ANGO) in Q3 2026: 92,500 shares worth $1.42M. The stake represents 0.01% of the portfolio and ranks #671 among its holdings.

58 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • Natixis held 92,500 shares of AngioDynamics worth $1.42M as of Q3 2026.
  • AngioDynamics was a new Natixis position in Q3 2026.
  • AngioDynamics made up 0.01% of Natixis's portfolio in Q3 2026, its #671 holding.
  • 58 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.